Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BIVV

Bioverativ

$56.11

0.82 (1.48%)

, RHHBY

Roche

$29.10

0.205 (0.71%)

09:08
11/20/17
11/20
09:08
11/20/17
09:08
Recommendations
Bioverativ, Roche analyst commentary at Piper Jaffray »

Piper a buyer of…

BIVV

Bioverativ

$56.11

0.82 (1.48%)

RHHBY

Roche

$29.10

0.205 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 09

    Dec

  • 23

    Dec

  • 23

    Feb

SHPG

Shire

$147.37

2.74 (1.89%)

, BIVV

Bioverativ

$56.11

0.82 (1.48%)

09:02
11/20/17
11/20
09:02
11/20/17
09:02
Hot Stocks
Shire, Bioverativ fall after Roche hemophilia A study hits goals »

Shares of Shire (SHPG)…

SHPG

Shire

$147.37

2.74 (1.89%)

BIVV

Bioverativ

$56.11

0.82 (1.48%)

RHHBY

Roche

$29.10

0.205 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 09

    Dec

  • 23

    Dec

  • 23

    Feb

RHHBY

Roche

$29.10

0.205 (0.71%)

08:56
11/20/17
11/20
08:56
11/20/17
08:56
Hot Stocks
Genentech says Phase III hemophilia A study met primary endpoint »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

JNJ

Johnson & Johnson

$138.00

-0.87 (-0.63%)

08:43
11/20/17
11/20
08:43
11/20/17
08:43
Hot Stocks
EU extends license for Janssen's Zytiga plus prednisone »

Janssen-Cilag…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ABBV

AbbVie

$93.61

-0.86 (-0.91%)

08:25
11/20/17
11/20
08:25
11/20/17
08:25
Recommendations
AbbVie analyst commentary at Cowen »

AbbVie estimates raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GERN

Geron

, JNJ

Johnson & Johnson

$138.00

-0.87 (-0.63%)

07:40
11/20/17
11/20
07:40
11/20/17
07:40
Hot Stocks
Geron doses first patient in expanded Part 1 of IMerge Phase 2/3 clinical trial »

Geron (GERN) announced…

GERN

Geron

JNJ

Johnson & Johnson

$138.00

-0.87 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 09

    Dec

  • 14

    Dec

ALNY

Alnylam

$127.51

1.13 (0.89%)

, SNY

Sanofi

$44.54

-0.11 (-0.25%)

07:03
11/20/17
11/20
07:03
11/20/17
07:03
Hot Stocks
Alnylam receives FDA breakthrough therapy designation for Patisiran »

Alnylam Pharmaceuticals…

ALNY

Alnylam

$127.51

1.13 (0.89%)

SNY

Sanofi

$44.54

-0.11 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

  • 14

    Dec

AAAP

Advanced Accelerator

$81.20

-0.04 (-0.05%)

, NVS

Novartis

$83.98

0.96 (1.16%)

06:20
11/20/17
11/20
06:20
11/20/17
06:20
Downgrade
Advanced Accelerator, Novartis rating change at JPMorgan »

Advanced Accelerator…

AAAP

Advanced Accelerator

$81.20

-0.04 (-0.05%)

NVS

Novartis

$83.98

0.96 (1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 26

    Jan

  • 17

    May

RHHBY

Roche

$29.10

0.205 (0.71%)

06:18
11/20/17
11/20
06:18
11/20/17
06:18
Hot Stocks
Breaking Hot Stocks news story on Roche »

Roche: Study showed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

RHHBY

Roche

$29.10

0.205 (0.71%)

06:17
11/20/17
11/20
06:17
11/20/17
06:17
Hot Stocks
Roche: Phase III IMpower150 study met co-primary endpoint of PFS »

Roche announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.